Mahmud Mossa-Basha1, Matthew Alexander2, Jeffrey H. Maki1, Wendy Cohen1, Daniel S Hippe1, Chun Yuan1, Hannu Huhdanpa1, and Tobias Saam3
1Radiology, University of Washington, Seattle, WA, United States, 2Radiology, University of California San Francisco, San Francisco, CA, United States, 3Radiology, Ludwig-Maximilians-Universität München, Munich, Germany
Synopsis
Prompt diagnosis of large artery vasculopathies is important to avoid significant morbidities that can arise from delayed diagnosis. This is difficult however, as patients frequently present with nonspecific sign and symptoms and luminal imaging techniques are limited in the detection of non-stenotic disease. Vessel wall imaging is an emerging technique for vasculopathy evaluation throughout the body. We compare quantitative and qualitative measures of 2D and 3D vessel wall imaging techniques in patients with suspected large artery vasculopathy.Introduction
Takayasu arteritis (TA) and giant cell arteritis (GCA) are
chronic, inflammatory large artery vasculopathies (LAV), that necessitate early
diagnosis as prompt initiation of treatment can prevent or delay the onset
disease-related morbidities including blindness, limb ischemia, and hemorrhage
secondary to chronic vessel stenosis, occlusion, aneurysm formation, and the
harmful side-effects of overtreatment in later stage disease(1-3).
Unfortunately, early detection has historically been difficult due to the vague
nonspecific clinical presentation, with most people presenting with nonspecific
symptoms, including dizziness, syncope, and fatigue and limitations of
laboratory evaluation(3 4). As a
result, accurate clinical diagnosis is often delayed by approximately 10-15.5
months from symptom onset, or even greater in pediatric patients(5 6).
Historically, diagnostic imaging in LAV has primarily relied on
luminal evaluation, specifically CT angiography (CTA) and MR angiography (MRA),
with studies aimed at establishing and grading the degree of vascular stenosis
or occlusion(7 8). Luminal
imaging techniques, however, can only detect disease involvement when
significant luminal narrowing is present (typically not the case early in the disease),
and provide limited soft tissue and vessel wall information(7-9). Thus,
imaging modalities that provide vessel wall information are particularly useful
when diagnosing and managing large vessel vasculitis syndromes.
There
has been a recent focus on vessel wall imaging using MR vessel wall imaging
techniques (VWI) that directly visualize the vessel wall itself in order to
establish vessel wall involvement by the presence or absence of enhancement
indicative of active inflammation(3 4 10-13). This study performs a quantitative and
qualitative comparison between 3D T1 VISTA (Philips Healthcare, Best, the
Netherlands) and 2D T1 black blood imaging of
the aorta and cervical arteries to determine the differential quality of each
technique in patients referred for suspicion of LAV.
Materials and Methods
MR Imaging Protocol:
Patients referred for evaluation of potential LAV who received
both 3D and 2D VWI MRI before and after contrast administration were included. The 3D and 2D sequences were performed in
random order for each patient. Imaging
parameters are in Table 1.
Image Analysis:
Blinded
independent review was performed by two experienced diagnostic
neuroradiologists. Blood signal suppression, image quality, and diagnostic confidence
were each rated using a four-point scale. The ratings from each
neuroradiologist were averaged for the data analysis. A separate rater
evaluated vessel wall and soft tissue SNR and CNR for cervical and aorta images
for both techniques. Two-tailed paired
t-tests were performed to compare differences between 2D and 3D techniques.
Results
Eight patients were recruited and underwent 2D and 3D imaging.
Cervical arteries were imaged in all patients while the aorta was imaged in 6
of 8. 2D VWI demonstrated significantly increased SNR and CNR of the vessel
wall (.031 and .026, respectively) for images of the cervical arteries. 3D
images had better soft tissue SNR (p=.005) for the thoracoabdominal aorta (Table 2).
Blood suppression, overall image quality and diagnostic confidence ratings of
the cervical images were significantly higher for the 3D images than the 2D
images (Table 3). For the aortic images, blood suppression and image quality
ratings were significantly higher for the 3D images than the 2D images (Table 4),
with a trend towards higher diagnostic confidence (p=0.054).
3D
imaging provided increased coverage relative to 2D imaging, with 300 (aorta)
and 200 (cervical) mm craniocaudal coverage, while 2D imaging provided 225 mm
(aorta) and 94 mm (cervical) coverage.
3D VWI scan time was shorter compared to 2D VWI (Table 1).
Discussion
Both 2D and 3D pulse sequences are useful for black blood MR
VWI. 3D sequences allow for increased coverage, higher resolution and multi-planar
reformats in a potentially shorter scan time. This current study compared 2D
and 3D VWI sequences obtained during the same study. Radiologist reviewers perceived
significantly improved blood suppression and image quality as well as increased
confidence in their ability to diagnose disease with 3D VWI techniques as
compared to 2D VWI. 3D VWI also provided
improved coverage in a shorter scan time and improved SNR for aortic imaging,
though decreased SNR and CNR in cervical evaluation, which may be related to signal
loss at the edge of the imaging field of view.
3D VWI using techniques such as VISTA for evaluation of LAV should be a
clinical consideration based on the above advantages as well as the ability to
perform multiplanar reformats.
Conclusion
3D VWI for evaluation of LAV should be a clinical
consideration based on radiologist-perceived advantages, improved coverage in a
shorter scan time.
Acknowledgements
No acknowledgement found.References
References
1. Boes CJ. Bayard Horton's clinicopathological description of giant cell
(temporal) arteritis. Cephalalgia : an international journal of headache 2007;27(1):68-75.
2. Borg FA, Dasgupta B.
Treatment and outcomes of large vessel arteritis. Best practice & research
Clinical rheumatology 2009;23(3):325-37.
3. Jiang L, Li D, Yan F,
et al. Evaluation of Takayasu arteritis activity by delayed contrast-enhanced
magnetic resonance imaging. International journal of cardiology 2012;155(2):262-7.
4. Choe YH, Han BK, Koh
EM, et al. Takayasu's arteritis: assessment of disease activity with
contrast-enhanced MR imaging. AJR American journal of roentgenology 2000;175(2):505-11.
5. Abularrage CJ,
Slidell MB, Sidawy AN, et al. Quality of life of patients with Takayasu's
arteritis. Journal of vascular surgery 2008;47(1):131-6; discussion 36-7.
6. Kerr GS, Hallahan CW,
Giordano J, et al. Takayasu arteritis. Annals of internal medicine 1994;120(11):919-29.
7. Gotway MB, Araoz PA,
Macedo TA, et al. Imaging findings in Takayasu's arteritis. AJR American
journal of roentgenology 2005;184(6):1945-50.
8. Wen D, Du X, Ma CS.
Takayasu arteritis: diagnosis, treatment and prognosis. International reviews
of immunology 2012;31(6):462-73.
9. Pipitone N, Versari
A, Salvarani C. Role of imaging studies in the diagnosis and follow-up of
large-vessel vasculitis: an update. Rheumatology (Oxford, England) 2008;47(4):403-8.
10. Aluquin VP, Albano
SA, Chan F, et al. Magnetic resonance imaging in the diagnosis and follow up of
Takayasu's arteritis in children. Annals of the rheumatic diseases 2002;61(6):526-9.
11. Bley TA, Markl M,
Schelp M, et al. Mural inflammatory hyperenhancement in MRI of giant cell
(temporal) arteritis resolves under corticosteroid treatment. Rheumatology (Oxford,
England) 2008;47(1):65-7.
12. Bley TA, Uhl M,
Carew J, et al. Diagnostic value of high-resolution MR imaging in giant cell
arteritis. AJNR American journal of neuroradiology 2007;28(9):1722-7.
13. Klink T, Geiger J,
Both M, et al. Giant cell arteritis: diagnostic accuracy of MR imaging of
superficial cranial arteries in initial diagnosis-results from a multicenter
trial. Radiology 2014;273(3):844-52.